Impaired arterial neointima formation in mice with disruption of the plasminogen gene.
Open accessThe DOI matches its Crossref record.
Abstract
To define the role of plasminogen (Plg) in the smooth muscle cell response after arterial wall injury, neointima formation was evaluated after electric injury of the femoral artery in plasminogen-deficient (Plg-/-) mice. The injury destroyed all medial smooth muscle cells, denuded the injured segment of intact endothelium, and induced transient platelet-rich mural thrombosis. In wild-type (Plg+/+) mice, vascular wound healing was characterized by lysis of the thrombus, transient infiltration of inflammatory cells, and progressive removal of necrotic debris and thrombosis. Topographic analysis revealed repopulation of the media and accumulation in the neointima of smooth muscle cells originating from the noninjured borders, which progressed into the necrotic center. In Plg-/- mice, wound healing was significantly impaired with delayed removal of necrotic debris, reduced leucocyte infiltration and smooth muscle cell accumulation, and decreased neointima formation. Smooth muscle cells accumulated at the uninjured borders, but failed to migrate into the necrotic center. Proliferation of smooth muscle cells was not affected by Plg deficiency. Evans blue staining revealed no genotypic differences in reendothelialization. Thus, Plg plays a significant role in vascular wound healing and arterial neointima formation after injury, most likely by affecting cellular migration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
uPAR: a versatile signalling orchestrator
Blasi, F., & Carmeliet, P. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm977 · Cited by 1,223
Self-citationDirect evidence for the importance of endothelium-derived nitric oxide in vascular remodeling.
Rudic, R. D., Shesely, E. G., Maeda, N., Smithies, O., Segal, S. S., & Sessa, W. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1699 · Cited by 821
Molecular mechanisms of fibrinolysis
Cesarman‐Maus, G., & Hajjar, K. A. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05444.x · Cited by 748
Matrix Metalloproteinases Regulate Neovascularization by Acting as Pericellular Fibrinolysins
Hiraoka, N., Allen, E., Apel, I. J., Gyetko, M. R., & Weiss, S. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81768-7 · Cited by 712
Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization
Bajou, K., Noël, A., Gerard, R. D., Masson, V., Brunner, N., Holst-Hansen, C., Skobe, M., Fusenig, N. E., Carmeliet, P., Collen, D., et al. (1998) · Nature Medicine · doi:10.1038/nm0898-923 · Cited by 677
Self-citationStructure and function of the plasminogen/plasmin system
Ploplis, V. A., & Castellino, F. J. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-12-0842 · Cited by 460
Self-citationPlasmin and Matrix Metalloproteinases in Vascular Remodeling
Lijnen, H. R. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616230 · Cited by 453
Interactions of Transforming Growth Factor-β and Angiotensin II in Renal Fibrosis
Border, W. A., & Noble, N. A. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.181 · Cited by 447
Fibroblast growth factor 2 control of vascular tone
Zhou, M., Sutliff, R. L., Paul, R. J., Lorenz, J. N., Hoying, J. B., Haudenschild, C. C., Yin, M., Coffin, J. D., Kong, L., Kranias, E. G., et al. (1998) · Nature Medicine · doi:10.1038/nm0298-201 · Cited by 380
Deficiency of cathepsin S reduces atherosclerosis in LDL receptor–deficient mice
Sukhova, G. K., Zhang, Y., Pan, J.-H., Wada, Y., Yamamoto, T., Naito, M., Kodama, T., Tsimikas, S., Witztum, J. L., Lu, M. L., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci14915 · Cited by 372
Khalil, N. (1999) · Microbes and Infection · doi:10.1016/s1286-4579(99)00259-2 · Cited by 341
Cho, A., & Reidy, M. A. (2002) · Circulation Research · doi:10.1161/01.res.0000040420.17366.2e · Cited by 319
Seetharam, D., Mineo, C., Gormley, A. K., Gibson, L. L., Vongpatanasin, W., Chambliss, K. L., Hahner, L. D., Cummings, M. L., Kitchens, R. L., Marcel, Y. L., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000199272.59432.5b · Cited by 285
The infarcted myocardium Simply dead tissue, or a lively target for therapeutic interventions
Cleutjens, J. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00212-6 · Cited by 268
Matrix metalloproteinases and cellular fibrinolytic activity
Lijnen, H. R. (2002) · Biochemistry (Moscow) · doi:10.1023/a:1013908332232 · Cited by 167
Metadata
- Authors
- Carmeliet, P., Moons, L., Ploplis, V, Plow, E., & Collen, D.
- Venue
- Journal of Clinical Investigation
- Published
- 1997-01-15
- Volume
- 99
- Issue
- 2
- Pages
- 200-208
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2025777610
- Cited by
- 187
- References
- 0
- FWCI
- 14.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.